You have 9 free searches left this month | for more free features.

infliximab

Showing 51 - 75 of 168

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ulcerative Colitis, Efficacy, Self, Biologics Trial in China (Infliximab, Vedolizumab, Mesalazine)

Not yet recruiting
  • Ulcerative Colitis
  • +3 more
  • Infliximab
  • +2 more
  • Chongqing, Chongqing, China
  • +10 more
Jan 11, 2022

Ulcerative Colitis Trial in France (Infliximab, Vedolizumab Injection)

Recruiting
  • Ulcerative Colitis
  • Infliximab
  • Vedolizumab Injection
  • Vannes, Bretagne, France
  • +19 more
Jan 5, 2021

IBD, Crohn Disease, Polyunsaturated Acid Lipidosis Trial (azathioprine, infliximab, N-3 Polyunsaturated Fatty Acids)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • +2 more
  • (no location specified)
Feb 18, 2021

Ulcerative Colitis Trial in France (Azathioprine, Infliximab, Prednisolone)

Recruiting
  • Ulcerative Colitis
  • Besancon, France
  • +15 more
Jan 19, 2021

Remsima® in Treatment of Inflammatory Bowel Diseases Among Saudi

Completed
  • Inflammatory Bowel Diseases
  • +3 more
  • Infliximab
  • Jeddah, Saudi Arabia
  • +3 more
Feb 22, 2021

Hepatosplenic T-Cell Lymphoma Trial in Norfolk (Infliximab, Golimumab)

Completed
  • Hepatosplenic T-Cell Lymphoma
  • Norfolk, Virginia
    (unnamed)
Feb 12, 2021

Breg and Treg With Clinical Effects of Infliximab in Treatment

Completed
  • Crohn Disease
  • Infliximab
  • Wenzhou, Zhejiang, China
    SAHWenzhouMU
Feb 13, 2020

IBD Trial in Canada, United States (Infliximab)

Terminated
  • Inflammatory Bowel Diseases
  • Infliximab
  • Phoenix, Arizona
  • +35 more
Jul 28, 2020

Crohn Disease Trial in Italy (Thalidomide, Infliximab)

Terminated
  • Crohn Disease
  • Napoli, Campania, Italy
  • +5 more
Sep 2, 2020

Participants Receiving Flixabi or Imraldi: a French Cohort Study

Completed
  • Arthritis, Rheumatoid
  • +4 more
  • Caluire et Cuire, Auvergne-Rhône-Alpes, France
  • +59 more
Oct 17, 2022

Mucocutaneous Lymph Node Syndrome Trial in United States (IVIG, Infliximab)

Completed
  • Mucocutaneous Lymph Node Syndrome
  • Birmingham, Alabama
  • +28 more
Nov 5, 2021

IBD Trial in Assiut (Infliximab)

Unknown status
  • Inflammatory Bowel Diseases
  • Infliximab
  • Assiut, Egypt
    Hyam Fathy
Jul 14, 2020

Ulcerative Colitis Trial in Worldwide (Etrolizumab, Infliximab, Placebo (IV))

Completed
  • Ulcerative Colitis
  • Salzburg, Austria
  • +118 more
Dec 1, 2021

Anti-TNF Therapy for Refractory Colitis in Hospitalized Children

Completed
  • Colitis, Ulcerative
  • Bowel Diseases, Inflammatory
  • Infliximab
  • Hartford, Connecticut
  • +6 more
Apr 8, 2020

Dermatomyositis, Polymyositis Trial run by the NIAMS (Infliximab)

Completed
  • Dermatomyositis
  • Polymyositis
  • Infliximab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 30, 2019

(CHOIR)

Recruiting
  • Chronic Nonbacterial Osteomyelitis
  • Chronic Recurrent Multifocal Osteomyelitis
  • Seattle, Washington
    Seattle Children's Hospital
Jan 25, 2021

Behcet Disease Trial in Korea, Republic of (Infliximab)

Completed
  • Behcet Disease
  • Infliximab
  • Busan, Korea, Republic of
  • +4 more
Oct 16, 2019

Rheumatoid Arthritis Trial in United States (Infliximab, Methotrexate, Methylprednisolone)

Terminated
  • Rheumatoid Arthritis
  • Infliximab
  • +4 more
  • Birmingham, Alabama
  • +52 more
Oct 13, 2020

Rheumatoid Arthritis Trial in Leeds (Infliximab, Methylprednisolone, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Infliximab
  • +3 more
  • Leeds, West Yorkshire, United Kingdom
    Chapel Allerton Hospital
Oct 30, 2019

Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

Recruiting
  • Clinical Stage 0 Cutaneous Melanoma AJCC v8
  • +43 more
  • Best Practice
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Rheumatoid Arthritis Trial in Italy (Tocilizumab, Etanercept, Infliximab)

Recruiting
  • Rheumatoid Arthritis
  • Bari, Italy
  • +21 more
Nov 12, 2020

Crohn's Disease Trial in Portland (Infliximab)

Withdrawn
  • Crohn's Disease
  • Infliximab
  • Portland, Oregon
    Oregon Health & Science University
May 6, 2019

Colitis, Ulcerative Trial in Worldwide (Golimumab, Infliximab)

Recruiting
  • Colitis, Ulcerative
  • San Francisco, California
  • +64 more
Aug 17, 2022

COVID-19 Trial in Canada (Artesunate, Imatinib, Infliximab)

Recruiting
  • COVID-19
  • Calgary, Alberta, Canada
  • +56 more
Jan 12, 2023

Reperfusion Injury Trial in Leuven (Antithrombin-III, Infliximab, Apotransferrin)

Completed
  • Reperfusion Injury
  • Leuven, Belgium
    University Hospitals Leuven
Aug 8, 2019